Louis Bazire

561 total citations
24 papers, 344 citations indexed

About

Louis Bazire is a scholar working on Cancer Research, Surgery and Oncology. According to data from OpenAlex, Louis Bazire has authored 24 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Louis Bazire's work include Breast Cancer Treatment Studies (9 papers), Colorectal and Anal Carcinomas (6 papers) and Breast Lesions and Carcinomas (5 papers). Louis Bazire is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Colorectal and Anal Carcinomas (6 papers) and Breast Lesions and Carcinomas (5 papers). Louis Bazire collaborates with scholars based in France, China and Italy. Louis Bazire's co-authors include Youlia Kirova, Alain Fourquet, Jean‐Philippe Foy, Yann De Rycke, Jean‐Yves Pierga, Anne Vincent‐Salomon, Haoping Xu, Bernard Asselain, Frédérique Berger and Caroline Malhaire and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Louis Bazire

23 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louis Bazire France	9	131	123	92	85	75	24	344
Mathieu Minsat France	12	156 1.2×	142 1.2×	196 2.1×	148 1.7×	94 1.3×	31	454
E. Van Limbergen Belgium	8	95 0.7×	98 0.8×	73 0.8×	98 1.2×	40 0.5×	26	372
Julie Cuartero Canada	7	235 1.8×	139 1.1×	165 1.8×	44 0.5×	75 1.0×	8	396
Timothy Ginader United States	10	44 0.3×	189 1.5×	81 0.9×	52 0.6×	95 1.3×	18	335
Mohammad Naser Forghani Iran	13	128 1.0×	173 1.4×	142 1.5×	113 1.3×	42 0.6×	29	494
Won Taek Kim South Korea	9	55 0.4×	67 0.5×	79 0.9×	92 1.1×	28 0.4×	23	288
Thomas Hendrik Knocke Austria	9	118 0.9×	69 0.6×	102 1.1×	59 0.7×	50 0.7×	12	364
Hiroshi Nishijima Japan	11	109 0.8×	145 1.2×	231 2.5×	90 1.1×	20 0.3×	17	398
Brian Khong United States	7	84 0.6×	121 1.0×	89 1.0×	96 1.1×	48 0.6×	12	374

Countries citing papers authored by Louis Bazire

Since Specialization

Citations

This map shows the geographic impact of Louis Bazire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Bazire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Bazire more than expected).

Fields of papers citing papers by Louis Bazire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Bazire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Bazire. The network helps show where Louis Bazire may publish in the future.

Co-authorship network of co-authors of Louis Bazire

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Bazire. A scholar is included among the top collaborators of Louis Bazire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Bazire. Louis Bazire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loap, Pierre, Delphine Loirat, Frédérique Berger, et al.. (2022). Safety and tolerability of olaparib combined with breast radiotherapy in patients with triple-negative breast cancer: Final results of the RADIOPARP phase 1 trial.. Journal of Clinical Oncology. 40(16_suppl). 534–534. 2 indexed citations

Quéro, L., Emilie Barbier, F. Juguet, et al.. (2021). What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort. Digestive and Liver Disease. 53(6). 776–784. 3 indexed citations

Kirova, Youlia, Delphine Loirat, Frédérique Berger, et al.. (2020). Radioparp: A phase I of olaparib with radiation therapy (RT) in patients with inflammatory, locoregionally advanced or metastatic triple-negative breast cancer (TNBC) or patient with operated TNBC with residual disease—Preliminary results.. Journal of Clinical Oncology. 38(15_suppl). 571–571. 5 indexed citations

Kirova, Youlia, Delphine Loirat, Frédérique Berger, et al.. (2020). Abstract OT2-03-01: A phase one trial of olaparib with radiation therapy in patients with triple negative breast cancer: RADIOPARP. Cancer Research. 80(4_Supplement). OT2–3. 1 indexed citations

Xu, Haoping, É. Costa, Louis Bazire, et al.. (2019). Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience. Cancer/Radiothérapie. 23(2). 116–124. 3 indexed citations

Aparicio, Thomas, Philippe Ronchin, Louis Bazire, et al.. (2019). Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase II study with panitumumab (FFCD 0904).. Journal of Clinical Oncology. 37(15_suppl). 3570–3570. 2 indexed citations

Cabel, Luc, Emmanuelle Jeannot, Ivan Bièche, et al.. (2018). Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma. Clinical Cancer Research. 24(22). 5767–5771. 65 indexed citations

Loganadane, Gokoulakrichenane, N. Fournier‐Bidoz, Haoping Xu, et al.. (2018). Caractérisation des rechutes locorégionales chez des patientes atteintes d’un cancer du sein traité par irradiation pariétale par électrons : expérience monocentrique de l’institut Curie. Cancer/Radiothérapie. 23(1). 38–45. 2 indexed citations

Bazire, Louis, et al.. (2018). Radiation therapy after sentinel lymph node biopsy for early stage breast cancer using a magnetic tracer: Results of a single institutional prospective study of tolerance. Cancer/Radiothérapie. 23(1). 23–27. 4 indexed citations

10.

Bazire, Louis, et al.. (2018). Place de la radiothérapie stéréotaxique extracrânienne dans la prise en charge des patients atteints de cancer. Cancer/Radiothérapie. 22(5). 447–458.

11.

Cabel, Luc, Emmanuelle Jeannot, Ivan Bièche, et al.. (2018). Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal canal carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 3565–3565. 2 indexed citations

12.

Carroll, Susan, et al.. (2018). Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment. British Journal of Radiology. 91(1085). 20170822–20170822. 5 indexed citations

13.

Loganadane, Gokoulakrichenane, et al.. (2017). Patterns of loco regional failure in women with breast cancer treated by Postmastectomy Conformal Electron Beam Radiation Therapy (PMERT): Large scale single center experience. Clinical and Translational Radiation Oncology. 4. 46–50. 8 indexed citations

14.

Dureau, Sylvain, Hao Xu, Louis Bazire, et al.. (2017). Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results. Radiotherapy and Oncology. 124(2). 214–219. 29 indexed citations

15.

Bazire, Louis, et al.. (2017). Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie en conditions stéréotaxiques : le cœur. Cancer/Radiothérapie. 21(6-7). 626–635. 4 indexed citations

16.

Buecher, Bruno, Antoine De Pauw, Louis Bazire, et al.. (2017). Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations. Familial Cancer. 17(2). 281–285. 6 indexed citations

17.

Foy, Jean‐Philippe, Louis Bazire, Sandra Ortiz‐Cuaran, et al.. (2017). A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes. BMC Medicine. 15(1). 165–165. 35 indexed citations

18.

Bazire, Louis, Yann De Rycke, Bernard Asselain, Alain Fourquet, & Youlia Kirova. (2016). Risks of second malignancies after breast cancer treatment: Long-term results. Cancer/Radiothérapie. 21(1). 10–15. 36 indexed citations

19.

Bazire, Louis, Isabelle Fromantin, Alhassane Diallo, et al.. (2015). Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. Radiotherapy and Oncology. 117(2). 229–233. 18 indexed citations

20.

Bendifallah, Sofiane, Geoffroy Canlorbe, Émilie Raimond, et al.. (2013). An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?. British Journal of Cancer. 109(6). 1498–1503. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact